SUBSTANCE-P BUT NOT VASOACTIVE-INTESTINAL-PEPTIDE MODULATES IMMUNOGLOBULIN SECRETION IN MURINE SCHISTOSOMIASIS

被引:15
作者
NEIL, GA
BLUM, A
WEINSTOCK, JV
机构
[1] Department of Internal Medicine, University of Iowa, Iowa City
关键词
D O I
10.1016/0008-8749(91)90284-I
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neuropeptides including SP and VIP modulate Ig secretion by in vitro stimulated lymphocyte cultures. It is not known whether these neuropeptides effect the B cell directly, or if they significantly alter humoral immune responses to pathogens. We have previously shown that granulomas derived from schistosome-infected mice contain immunoglobulin secreting B cells (ISC) as well as eosinophils that secrete substance P (SP) and vasoactive intestinal peptide (VIP). It therefore seemed plausible that B cells derived from infected animals might respond to these neuropeptides, and that such responses might effect immunoregulatory signals. In this study, we addressed these issues in the murine Schistosoma mansoni model, at the level of immunoglobulin secretion in single B cells. Spontaneous ISC were observed in both splenic and granuloma cell preparations. The addition of SP resulted in a dose-dependent reduction in the number and size of plaques (a 50% reduction was observed at 10-9M). This effect was blocked with SP antagonists. Similar results were observed in T cell-depleted cell cultures. VIP had no effect on ISC number or plaque size. We conclude that SP, but not VIP, decreases spontaneous ISC number and Ig secretion in short-term cultures of spleen and granuloma cells. SP appears to exert its effects at the level of single B cells through a receptor-mediated mechanism and may thus play an immunoregulatory role in schistosomiasis. © 1991.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 20 条
[1]   COMPLEMENTARY-DNA FOR A NOVEL HUMAN INTERLEUKIN (BSF-2) THAT INDUCES LYMPHOCYTES-B TO PRODUCE IMMUNOGLOBULIN [J].
HIRANO, T ;
YASUKAWA, K ;
HARADA, H ;
TAGA, T ;
WATANABE, Y ;
MATSUDA, T ;
KASHIWAMURA, S ;
NAKAJIMA, K ;
KOYAMA, K ;
IWAMATSU, A ;
TSUNASAWA, S ;
SAKIYAMA, F ;
MATSUI, H ;
TAKAHARA, Y ;
TANIGUCHI, T ;
KISHIMOTO, T .
NATURE, 1986, 324 (6092) :73-76
[2]   FACTORS AFFECTING B-CELL GROWTH AND DIFFERENTIATION [J].
KISHIMOTO, T .
ANNUAL REVIEW OF IMMUNOLOGY, 1985, 3 :133-157
[3]  
KISHIMOTO T, 1975, J IMMUNOL, V114, P585
[4]   GASTROINTESTINAL REGULATORY PEPTIDES MODULATE INVITRO IMMUNE-REACTIONS OF MOUSE LYMPHOID-CELLS [J].
KRCO, CJ ;
GORES, A ;
GO, VLW .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 39 (02) :308-318
[5]   ISOLATION AND CHARACTERIZATION OF A MOUSE INTERLEUKIN CDNA CLONE THAT EXPRESSES B-CELL STIMULATORY FACTOR-I ACTIVITIES AND T-CELL-STIMULATING AND MAST-CELL-STIMULATING ACTIVITIES [J].
LEE, F ;
YOKOTA, T ;
OTSUKA, T ;
MEYERSON, P ;
VILLARET, D ;
COFFMAN, R ;
MOSMANN, T ;
RENNICK, D ;
ROEHM, N ;
SMITH, C ;
ZLOTNIK, A ;
ARAI, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (07) :2061-2065
[6]   INCREASE OF SUBSTANCE-P IN PRIMARY AFFERENT NERVES DURING CHRONIC PAIN [J].
LEMBECK, F ;
DONNERER, J ;
COLPAERT, FC .
NEUROPEPTIDES, 1981, 1 (03) :175-180
[7]   CHARACTERIZATION OF NEUROPEPTIDE-INDUCED HISTAMINE-RELEASE FROM HUMAN DISPERSED SKIN MAST-CELLS [J].
LOWMAN, MA ;
BENYON, RC ;
CHURCH, MK .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (01) :121-130
[8]  
NORLIND K, 1986, INT ARCH ALLER A IMM, V80, P326
[9]  
OTTAWAY CA, 1984, J IMMUNOL, V132, P417
[10]  
PAYAN DG, 1984, J IMMUNOL, V133, P3260